Capital Analysts, LLC VRCA — VERRICA PHARMACEUTICALS INC

Ownership history in Capital Analysts, LLC  ·  8 quarters on record

AI Ownership Summary

Capital Analysts, LLC reported VERRICA PHARMACEUTICALS INC (VRCA) in 8 quarterly 13F filings from 2024 Q3 through 2026 Q2. The latest visible filing shows VRCA at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this VRCA ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Capital Analysts, LLC's position in VERRICA PHARMACEUTICALS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q2

VRCA was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2024 Q3

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q3 to 2026 Q2

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

VRCA stock page Capital Analysts, LLC fund profile Capital Analysts, LLC full holdings
How Capital Analysts, LLC held VRCA — position size vs. price
% of Fund (quarterly)    VRCA price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 8 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q2 UNCHANGED — — — 1,500 — 0% 0.00% $9 2026-08-05 $5.51
2026 Q1 UNCHANGED — — — 1,500 — 0% 0.00% $8 2026-05-15 $6.27
2025 Q4 UNCHANGED — — — 1,500 — 0% 0.00% $12K 2026-02-11 $5.69
2025 Q3 REDUCED 93.0% +90.3% ❌ 1,500 -19,800 -93.0% 0.00% $6K 2025-11-14 $3.93
2025 Q2 ADDED — — — 21,300 +5,000 +30.7% 0.00% $11K 2025-08-13 $6.59
2025 Q1 ADDED — — — 16,300 +3,000 +22.6% 0.00% $7K 2025-05-14 $5.35
2024 Q4 ADDED — — — 13,300 +7,000 +111.1% 0.00% $9K 2025-02-14 $7.37
2024 Q3 INITIATED — — — 6,300 — — 0.00% $9K 2024-11-13 $8.46

🏢 Other funds also holding VRCA

As of 2026 Q2 — sorted by position size

Legacy Trust 3Y 0.02% Allied Private Wealth LLC 0.0% New England Capital Financial Advisors LLC 3Y 0.0% Fortitude Family Office, LLC 0.0% Salomon & Ludwin, LLC 3Y 7Y 0.0% FIFTH THIRD BANCORP 3Y 7Y 0.0% Tower Research Capital LLC (TRC) 3Y 7Y 0.0% INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC 3Y 0.0% VALLEY NATIONAL ADVISERS INC 3Y 7Y 0.0% DIMENSIONAL FUND ADVISORS LP 3Y 7Y 0.0%

FAQ About Capital Analysts, LLC and VRCA

These are the practical questions this page is built to answer before you even open the full history table.

How long has Capital Analysts, LLC reported owning VRCA?

Capital Analysts, LLC reported VRCA across 8 quarterly 13F filings, from 2024 Q3 through 2026 Q2.

What was the largest reported VRCA position in Capital Analysts, LLC's portfolio?

The largest reported portfolio weight for VRCA was 0.00% in 2024 Q3.

What is the latest reported VRCA position on this page?

The most recent filing on this page is 2026 Q2, when Capital Analysts, LLC reported 1,500 shares, equal to 0.00% of portfolio, with an estimated market value of $9.

What does the chart on this VRCA ownership page compare?

The chart compares Capital Analysts, LLC's quarterly VRCA portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Capital Analysts, LLC time their VRCA position?

Based on 13F filing dates vs. subsequent VRCA price moves, Capital Analysts, LLC correctly timed 1 out of 5 reported position changes (20%). The annualised alpha on VRCA relative to SPY over the holding period was -33.5%.

← Back to Capital Analysts, LLC Holdings